Deciphering protective genomic factors of tumor development in pediatric Down syndrome via deep learning approach to whole genome and RNA sequencing

Yichuan Liu; Hui-Qi Qu; Xiao Chang; Frank D Mentch; Haijun Qiu; Kenny Nguyen; Kayleigh Ostberg; Tiancheng Wang; Joseph Glessner; Hakon Hakonarson

doi:10.1002/cac2.12612

Cancer Communications ›› 2024, Vol. 44 ›› Issue (11) : 1374 -1378. DOI: 10.1002/cac2.12612

LETTER TO THE JOURNAL

Deciphering protective genomic factors of tumor development in pediatric Down syndrome via deep learning approach to whole genome and RNA sequencing

Author information +

History +

PDF

Cite this article

Download citation ▾

Yichuan Liu, Hui-Qi Qu, Xiao Chang, Frank D Mentch, Haijun Qiu, Kenny Nguyen, Kayleigh Ostberg, Tiancheng Wang, Joseph Glessner, Hakon Hakonarson. Deciphering protective genomic factors of tumor development in pediatric Down syndrome via deep learning approach to whole genome and RNA sequencing. Cancer Communications, 2024, 44(11): 1374-1378 DOI:10.1002/cac2.12612

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Hasle H, Friedman JM, Olsen JH, Rasmussen SA. Low risk of solid tumors in persons with Down syndrome. Genet Med. 2016; 18(11): 1151-7.

[2]	Osuna-Marco MP, López-Barahona M, López-Ibor B, Tejera ÁM. Ten reasons why people with down syndrome are protected from the development of most solid tumors-a review. Front Genet. 2021; 12: 749480.

[3]	Satgé D, Bénard J, editors. Carcinogenesis in Down syndrome: What can be learned from trisomy 21? Semin Cancer Biol. 2008: 18(5): 365-71.

[4]	Pomerantz JH, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development. 2013; 140(12): 2502-12.

[5]	Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy. Nat Rev Clin Oncol. 2021; 18(10): 645-61.

[6]	Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014; 14(2): 77-91.

[7]	Jantrapirom S, Lo Piccolo L, Pruksakorn D, Potikanond S, Nimlamool W. Ubiquilin networking in cancers. Cancers. 2020; 12(6): 1586.

[8]	Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, et al. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Res. 2011; 71(24): 7587-96.

[9]	Zhu Y-c, Wang W-x, Li X-l. Xu C-w, Chen G, Zhuang W, et al. Identification of a novel icotinib-sensitive EGFR-SEPTIN14 fusion variant in lung adenocarcinoma by next-generation sequencing. J Thorac Oncol. 2019; 14(8): e181-e3.